REDWOOD CITY, Calif., Jan. 25, 2016 -- Cardica, Inc. (Nasdaq:CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2015, on Thursday, February 4, 2016, after the markets close. Cardica’s management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company’s business.
Conference Call Details
To access the live conference call on February 4, 2016, at 4:30 p.m. Eastern Time via phone, please dial 800-901-5241 from the United States and Canada or 617-786-2963 internationally. The conference ID is 61547195. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately four hours after the call through February 11, 2016, and may be accessed by dialing 888-286-8010 from the United States and Canada or 617-801-6888 internationally. The replay passcode is 80216818.
To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company’s website at www.cardica.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
The webcast is also being distributed through the Thomson StreetEvents Network. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.
About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and minimally invasive surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally invasive and robot-assisted surgeries. Cardica’s MicroCutter XCHANGE® 30, that includes a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter and staples, is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine and the transection of the appendix. The MicroCutter XCHANGE 30 White Cartridge staple has application in vascular tissue. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 56,500 units throughout the world.
Contact: Bob Newell Vice President, Finance and Chief Financial Officer (650) 331-7133 [email protected]


Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally
Uber to Acquire Delivery Hero in $14.8 Billion Deal to Expand Global Food Delivery Business
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 



